CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
HYPERMARKER aims to enhance hypertension treatment by using pharmacometabolomics to tailor antihypertensive therapy. The project will analyze metabolomic profiles from diverse cohorts to develop AI-driven prediction models for individual treatment responses, ultimately creating a clinical decision support tool for heal…
Hypertension, or high blood pressure (BP), is a serious medical condition, and the single biggest contributor to circulatory diseases which continue to dominate as the leading cause of death and morbidity across the EU.
It accounts for almost 10 percent of all healthcare-related costs.
Systolic hypertension leads to a broad variety of diseases with an immense impact on both patients and healthcare systems.HYPERMARKER will unleash the potential of pharmacometabolomics to provide a ‘smart’ prescri…
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Hamburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Bunnik
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
